Preliminary analysis of treatment in 32 patients with critical severe acute respiratory syndrome

OBJECTIVE: To summarize the experience of treatment in 32 critical severe acute respiratory syndrome (SARS) patients

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 15(2003), 8 vom: 15. Aug., Seite 492-4
1. Verfasser: Lu, Wei (VerfasserIn)
Weitere Verfasser: Zhang, Hong-sheng, Wang, Feng-mei, Wang, Shao-jun, Wu, Xiao-di, Zhang, Na-xin, Kan, Zhi-chao, Qin, Ying-zhi, Xiao, Lang
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2003
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:English Abstract Journal Article
Beschreibung
Zusammenfassung:OBJECTIVE: To summarize the experience of treatment in 32 critical severe acute respiratory syndrome (SARS) patients
METHODS: The age of 32 patients ranged from 19 to 72 years, the average was 43.06 years. Among them, 13 patients were having serious primary diseases, i.e. cardio-cerebral-vascular disease in 9 patients, diabetes in 2 patients, renal dysfunction in 1 patient, and chronic obstructive pulmonary disease (COPD) in 1 patient. The treatment included antiviral agents, glucocorticoid, mechanical ventilation, antibiotics and immunologic enhancement, etc. Cure rate, mortality and complications were analyzed
RESULTS: Among 32 patients, 24 were cured, 2 died of respiratory failure, 6 died of their primary diseases, and the overall mortality was 25.00 percent. Superimposed infection occurred in 12 patients, and among 17 patients who required noninvasive ventilation, 3 patients were complicated by lung injury (mediastinal emphysema, pneumothorax). In addition, hyperglycemia was found in 4 patients, upper intestinal hemorrhage occurred in another 4 patients and cardiac failure occurred in 6 patients
CONCLUSION: The treatment of the pre-existing diseases should be emphasized in the treatment of critical SARS. Glucocorticoid should not be used for a long-term. Vigilance should be paid to avoid lung injury during mechanical ventilation
Beschreibung:Date Completed 24.03.2016
Date Revised 15.08.2003
published: Print
Citation Status MEDLINE
ISSN:1003-0603